Devlyn Optical Partnering with Eyenuk to Offer Diabetic Retinopathy Screening Los Angeles, CA, June 8, 2020 — Eyenuk, Inc. and Devlyn Optical, a spin-off of Grupo Devlyn, a multinational optical …
Researchers from Moorfields Eye Hospital, Homerton NHS Trust, and University College London find EyeArt System to have 100% sensitivity in detecting vision-threatening retinopathy Los Angeles, CA, May 19, 2020 — …
British Journal of Ophthalmology Publishes Strong EyeArt Accuracy Results Read More »
Partnering with Eyenuk to Identify At-Risk Patients Using Telemedicine and AI VIRGINIA BEACH, VA, May 4, 2020 —Wagner Macula & Retina Center (WMRC), a leading research and treatment center specializing …
ENGLAND, April 15, 2020 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced that it …
LOS ANGELES, April 2, 2020 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today …
Eyenuk Reports Strong First Quarter 2020 Commercial Results Read More »
LOS ANGELES, January 21, 2019 — Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today …
Leading Medical Retina Center in Italy Adopts Eyenuk’s EyeArt AI Eye Screening System Read More »
In cooperation with the World Diabetes Foundation and the Ministry of Health of Armenia, the Armenian EyeCare Project is implementing a nationwide screening program using state-of-the-art AI technology. 350 patients …
LOS ANGELES, Oct. 10, 2019 – Imagine if the very first signs of dementia, before any significant memory or other physiological changes are apparent, could be identified via a simple …
Landmark Study of Over 100,000 Diabetes Patient Visits Published in the Journal Diabetes Technology and Therapeutics Validates the Prowess of the EyeArt AI System for Diabetic Retinopathy Screening LOS ANGELES, …
LOS ANGELES, June 5, 2019 – Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today …
LOS ANGELES, CA, May 16, 2019 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced …
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it will release results …
LOS ANGELES, Calif., April 28, 2019 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced …
APRIL 11 2019, LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today the …
– 30 Centers Across Italy Will Provide AI Eye Screening for Diabetic Retinopathy, the Leading Cause of Vision Loss Among Working-age Adults – LOS ANGELES–Eyenuk Inc., a global artificial intelligence …
LOS ANGELES, California, Oct. 2, 2018 – Eyenuk, Inc. announces its expansion into Germany with the adoption of EyeArt® artificial intelligence (AI) technology for the screening of diabetic retinopathy at …
WOODLAND HILLS, Calif. – June 29, 2016 – Eyenuk, Inc., developer of advanced retinal image analysis solutions to identify eye disease, today announced receipt of the CE Mark and the …
Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced image analysis tools for automated high-throughput screening of diabetic retinopathy. The company …
